2014
DOI: 10.1002/ebch.1984
|View full text |Cite
|
Sign up to set email alerts
|

Cochrane in context: Inhaled corticosteroids in children with persistent asthma: effects on growth and dose–response effects on growth

Abstract: Cochrane Review: Inhaled corticosteroids in children with persistent asthma: effects on growth Zhang L, Prietsch SOM, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD009471. DOI: 10.1002/14651858.CD009471.pub2Cochrane Review: Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth Pruteanu AI, Chauhan BF, Zhang L, Prietsch SOM, Ducharme FM. Inhaled corticosteroids i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Asthmatic children when treated with low-dose ICS attain normal adult height but at a later age (Evidence A). [ 321 322 ] Any potential adverse effects of ICS need to be weighed against the well-established benefit to control persistent asthma. More details of the use of ICS in children is available in Appendix 2 There are insufficient data to recommend short courses of high-dose ICS in children with mild intermittent asthma exacerbations (Evidence B).…”
Section: Methodsmentioning
confidence: 99%
“…Asthmatic children when treated with low-dose ICS attain normal adult height but at a later age (Evidence A). [ 321 322 ] Any potential adverse effects of ICS need to be weighed against the well-established benefit to control persistent asthma. More details of the use of ICS in children is available in Appendix 2 There are insufficient data to recommend short courses of high-dose ICS in children with mild intermittent asthma exacerbations (Evidence B).…”
Section: Methodsmentioning
confidence: 99%
“…However, asthmatic children when treated with low-dose ICS attain normal adult height but at a later age (Evidence A). [329330] Any potential adverse effects of ICS need to be weighed against the well-established benefit to control persistent asthma. More details of the use of ICS in children are available in Appendix 1There are insufficient data to recommend short courses of high-dose ICS in children with mild intermittent asthma attacks (Evidence B).…”
Section: Management Of Asthma In Childrenmentioning
confidence: 99%
“…The inhibitory effect on growth has been shown to be dose‐dependent and seems to be related to the suppression of bone formation and inhibition at various levels of the growth hypothalamic‐pituitary axis and adrenal function . It has also been evidenced that the effect of ICs on linear growth is associated more strongly with the IC molecule than with the absolute dose . IC molecules have a different therapeutic index, being related to receptor affinity, pulmonary, and oral bioavailability , and they differ even when they are used at the same dose .…”
mentioning
confidence: 99%
“…It has also been evidenced that the effect of ICs on linear growth is associated more strongly with the IC molecule than with the absolute dose . IC molecules have a different therapeutic index, being related to receptor affinity, pulmonary, and oral bioavailability , and they differ even when they are used at the same dose .…”
mentioning
confidence: 99%